NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)

CompletedN/A

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions: Neuropathic Pain

Interventions: Pregabalin (Lyrica) capsule

The objective of this investigation is to evaluate the safety and efficacy of long term use with Lyrica in medical practice. Also, occurrence of unknown and known adverse drug reactions (ADRs) in subjects treated with Lyrica will be monitored during the survey period, and whether an additional treatment outcome investigation and/or a post-marketing clinical study is required in the future will be determined.

Eligibility overview

Sex: ALL

Age: 0 Days to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients need to be administered by Lyrica for over 52 weeks in order to be enrolled in the surveillance.

Exclusion Criteria:

* Patients not administered Lyrica.